Pharmacovigilance Solutions

Safety intelligence.
Compliance you
can count on.

End-to-end pharmacovigilance built for the complexity of modern drug safety — from clinical development through post-marketing surveillance.

0+
Regulatory Inspections, No Critical Findings
0%
of Clients Outsource Full-Service PV to UBC
Global
Regulatory Coverage Across All Regions

Regulatory compliance at the forefront of patient safety — across every product type, every market, every stage of development.

Our PV Approach

Why Partners Choose UBC.

Deep clinical expertise, purpose-built technology, and a global regulatory intelligence team — working as an extension of your PV organization.

Purpose-Built Technology

Proprietary PV software drives efficiency, accuracy, and quality — with real-time signal detection, automated case processing, and literature review built in.

Global Regulatory Reach

Our PV Process Excellence Team continuously monitors global regulatory changes, ensuring your program stays compliant across every country of interest.

True Collaboration

UBC functions as a seamless extension of your PV team — with established governance models, transparent communication, and shared accountability.

Flexible & Scalable

From full-service outsourcing to targeted support, UBC offers customizable PV solutions — including scalable, cost-effective case processing staffing models.

Prepared for you.

Five resources selected for biopharma safety leaders navigating complex pharmacovigilance challenges.

White Paper

Best practices for pharmacovigilance safety data management

Guidance on managing expanding volumes and complexity of safety data, including practical approaches to maintaining data quality, meeting regulatory requirements, and leveraging automation and AI to support scalable operations.

Download →
Blog

Redefining PV Skillsets in an AI-Driven World: Training the Next Generation of Safety Scientists

An overview of how evolving AI capabilities are reshaping pharmacovigilance roles, highlighting the growing importance of combining clinical expertise with data literacy, AI fluency, and human oversight.

Read the Blog →
Blog

Navigating the AI Landscape: Choosing the Right Model for Your PV Needs

An overview of different AI model types and their applications in pharmacovigilance, with guidance on aligning tools to specific workflows to improve efficiency, insight generation, and compliant decision-making.

Read the Blog →
Blog

Putting a Seatbelt on AI: How Risk-Based Integration is Transforming Drug Safety

A perspective on integrating AI into pharmacovigilance through structured, risk-based frameworks that enable operational efficiency while maintaining patient safety, data integrity, and regulatory compliance.

Read the Blog→
Fact Sheet

Global PV Excellence: Advanced solutions for patient safety

A high-level overview of UBC’s global pharmacovigilance solutions, including end-to-end safety services, regulatory expertise, and scalable approaches to maintaining compliance and protecting patient safety across the product lifecycle.

Download →

Built for rigor. Designed for
trust. Delivered with precision.

30+ regulatory inspections with no critical findings — because patient safety is not a checkbox, it is our core responsibility.

Talk to Our PV Team

Let us strengthen your PV program.

Whether you need full-service outsourcing or targeted support, our pharmacovigilance experts are ready to build a solution around your needs.

Contact UBC →

 

UBC logo white

Thank You for Connecting with UBC

.

 

What You Can Expect Next

.

UBC logo white

Get Ready to Change Your Business

.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.